Butenafinum_[INN-Latin]
Category
Butenafinum_[INN-Latin] Brand names, Butenafinum_[INN-Latin] Analogs
Butenafinum_[INN-Latin] Brand Names Mixture
No information avaliable
Butenafinum_[INN-Latin] Chemical_Formula
C23H27N
Butenafinum_[INN-Latin] RX_link
http://www.rxlist.com/cgi/generic2/butenafine.htm
Butenafinum_[INN-Latin] fda sheet
Butenafinum_[INN-Latin] msds (material safety sheet)
Butenafinum_[INN-Latin] Synthesis Reference
No information avaliable
Butenafinum_[INN-Latin] Molecular Weight
317.467 g/mol
Butenafinum_[INN-Latin] Melting Point
No information avaliable
Butenafinum_[INN-Latin] H2O Solubility
Slightly soluble (HCl salt)
Butenafinum_[INN-Latin] State
Solid
Butenafinum_[INN-Latin] LogP
7.12
Butenafinum_[INN-Latin] Dosage Forms
Cream (10 mg drug per gram of cream)
Butenafinum_[INN-Latin] Indication
For the topical treatment of the following dermatologic infections: tinea (pityriasis) versicolor due to M. furfur, interdigital tinea pedis (athlete’s foot), tinea corporis (ringworm) and tinea cruris (jock itch) due to E. floccosum, T. mentagrophytes, T. rubrum, and T. tonsurans.
Butenafinum_[INN-Latin] Pharmacology
Butenafine is an antifungal agent that acts by inhibiting squalene epoxidase, thus blocking the biosynthesis of ergosterol, an essential component of fungal cell membranes. It is mainly active against dermatophytes and has superior fungicidal activity against this group of fungi when compared to that of terbinafine, naftifine, tolnaftate, clotrimazole, and bifonazole. It is active also against Candida albicans and this activity is superior to that of terbinafine and naftifine. Butenafine also generates low MICs for Cryptococcus neoformans and Aspergillus spp. as well.
Butenafinum_[INN-Latin] Absorption
The total amount absorbed through the skin into the systemic circulation has not been quantified.
Butenafinum_[INN-Latin] Toxicity
No information avaliable
Butenafinum_[INN-Latin] Patient Information
Butenafinum_[INN-Latin] Organisms Affected
Fungi